BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 10613501)

  • 21. Ligand-binding properties and N-glycosylation of alpha 1 subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate(AMPA)-selective glutamate receptor channel expressed in a baculovirus system.
    Kawamoto S; Hattori S; Oiji I; Hamajima K; Mishina M; Okuda K
    Eur J Biochem; 1994 Jul; 223(2):665-73. PubMed ID: 7519985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor antagonists differentially suppress dorsal horn neuron responses to mechanical stimuli in rats with peripheral nerve injury.
    Leem JW; Choi EJ; Park ES; Paik KS
    Neurosci Lett; 1996 Jun; 211(1):37-40. PubMed ID: 8809842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nimodipine inhibits TMB-8 potentiation of AMPA-induced hippocampal neurodegeneration.
    Bernal F; Petegnief V; Rodríguez MJ; Ursu G; Pugliese M; Mahy N
    J Neurosci Res; 2009 Apr; 87(5):1240-9. PubMed ID: 19006087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
    Alici K; Gloveli T; Schmitz D; Heinemann U
    Neuroscience; 1997 Mar; 77(1):97-109. PubMed ID: 9044378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Ball EF; Shaw PJ; Ince PG; Johnson M
    Brain Res; 1994 Sep; 658(1-2):209-18. PubMed ID: 7834343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA synthesis-dependent potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated toxicity by antihistamine terfenadine in cultured rat cerebellar neurons.
    Díaz-Trelles R; Novelli A; Fernández-Sánchez MT
    Neurosci Lett; 2003 Jul; 345(2):136-40. PubMed ID: 12821189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes.
    Chéramy A; Desce JM; Godeheu G; Glowinski J
    Neurochem Int; 1994 Aug; 25(2):145-54. PubMed ID: 7994195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative autoradiography of 5-[3H]6-cyano-7-nitro-quinoxaline-2,3-dione and (+)-3-[3H]dizocilpine maleate binding in rat vestibular nuclear complex after unilateral deafferentation, with comparison to cochlear nucleus.
    Li H; Godfrey DA; Rubin AM
    Neuroscience; 1997 Mar; 77(2):473-84. PubMed ID: 9472405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
    Malva JO; Carvalho AP; Carvalho CM
    Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective alterations in glutamate receptor subtypes after unilateral orbital enucleation.
    Chalmers DT; McCulloch J
    Brain Res; 1991 Feb; 540(1-2):255-65. PubMed ID: 1647245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice.
    Mennini T; Cagnotto A; Carvelli L; Comoletti D; Manzoni C; Muzio V; Rizzi M; Vezzani A
    Eur J Neurosci; 1999 May; 11(5):1705-10. PubMed ID: 10215924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
    Hanania T; Johnson KM
    Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic characterization of [3H]6-cyano-7-nitroquinoxaline-2,3-dione binding sites in adult chick brain.
    Zavitsanou K; Mitsacos A; Kouvelas ED
    Neuroscience; 1994 Oct; 62(3):955-62. PubMed ID: 7532837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spreading depression induces expression of calcium-independent protein kinase C subspecies in ischaemia-sensitive cortical layers: regulation by N-methyl-D-aspartate receptors and glucocorticoids.
    Koponen S; Keinänen R; Roivainen R; Hirvonen T; Närhi M; Chan PH; Koistinaho J
    Neuroscience; 1999; 93(3):985-93. PubMed ID: 10473263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential brain area vulnerability to long-term subcortical excitotoxic lesions.
    Mahy N; Bendahan G; Boatell ML; Bjelke B; Tinner B; Olson L; Fuxe K
    Neuroscience; 1995 Mar; 65(1):15-25. PubMed ID: 7538642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S; Schliebs R; Bigl V
    Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different nitric oxide synthase inhibitors cause rapid and differential alterations in the ligand-binding capacity of transmitter receptors in the rat cerebral cortex.
    Bidmon HJ; Wu J; Palomero-Gallagher N; Oermann E; Mayer B; Schleicher A; Zilles K
    Ann Anat; 1999 Jul; 181(4):345-51. PubMed ID: 10427371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.